Date updated:05-31-2007
No description available

-
GNVC
Genvec - $1.0801
- 0.00%
- $N/A
No Analysis added

-
EXEL
Exelixis - $6.94
- +1.46%
- $6.93
No Analysis added

-
NRGN
Neurogen Corporat - $0.17
- +9.61%
- $0.17
No Analysis added

-
DNA
N/a - $80.43
- 0.00
- $80.43
No Analysis added

-
IMGN
Immunogen - $8.06
- +2.28%
- $7.93
No Analysis added

-
CPHD
Cepheid - $12.77
- 0.00%
- $N/A
No Analysis added
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Dec. 2, 2009 It’s been a tough year for regional banks. While investors mulled over the fate of the big three banks -- Citigroup (C), Ban...
By Jonas Elmerraji Posted on Dec. 1, 2009 After an earnings season that has brought a significant stream of dividend-increasers, stocks are taking a step back, with jus...
By Roberto Pedone Posted on Dec. 1, 2009 Bullish and Bearish: Each week, Barron’s publishes bullish and bearish stories on a variety of stocks. We present summaries o...
Posted on Dec. 1, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is to gather as much in...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is the stock list of some of the largest % losers from Dec. 1, 2009. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more
These are the stocks from Jim Cramer's Dec. 1 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more











Comments not available